Bruno Sterlini

Affiliated Researcher

IIT Publications

  • 2018
  • Fruscione F., Valente P., Sterlini B.iit, Romei A.iit, Baldassari S., Fadda M., Prestigio C.iit, Giansante G., Sartorelli J., Rossi P., Rubio A., Gambardella A., Nieus T., Broccoli V., Fassio A.iit, Baldelli P.iit, Corradi A.iit, Zara F., Benfenati F.iit
    DOI

    PRRT2 controls neuronal excitability by negatively modulating Na+ channel 1.2/1.6 activity

    Brain, vol. 141, (no. 4), pp. 1000-1016
  • 2017
  • Michetti C.iit, Castroflorio E.iit, Marchionni I.iit, Forte N.iit, Sterlini B., Binda F.iit, Fruscione F., Baldelli P.iit, Valtorta F., Zara F., Corradi A.iit, Benfenati F.iit
    DOI

    The PRRT2 knockout mouse recapitulates the neurological diseases associated with PRRT2 mutations

    Neurobiology of Disease, vol. 99, pp. 66-83
  • Moruzzo D.iit, Nobbio L., Sterlini B., Consalez G.G., Benfenati F.iit, Schenone A., Corradi A.
    DOI

    The Transcription Factors EBF1 and EBF2 Are Positive Regulators of Myelination in Schwann Cells

    Molecular Neurobiology, vol. 54, (no. 10), pp. 8117-8127
  • 2016
  • Rossi P., Sterlini B.iit, Castroflorio E.iit, Marte A., Onofri F., Valtorta F., Maragliano L.iit, Corradi A., Benfenati F.iit
    DOI

    A novel topology of proline-rich transmembrane protein 2 (PRRT2): Hints for an intracellular function at the synapse

    Journal of Biological Chemistry, vol. 291, (no. 12), pp. 6111-6123
  • Valente P., Castroflorio E.iit, Rossi P., Fadda M., Sterlini B.iit, Cervigni R.I., Prestigio C.iit, Giovedi S., Onofri F., Mura E., Guarnieri F.C., Marte A., Orlando M.iit, Zara F., Fassio A.iit, Valtorta F., Baldelli P.iit, Corradi A., Benfenati F.iit
    DOI

    PRRT2 Is a Key Component of the Ca2+-Dependent Neurotransmitter Release Machinery

    Cell Reports, vol. 15, (no. 1), pp. 117-131
  • 2015
  • Fornaro M., Escelsior A., Rocchi G., Conio B., Magioncalda P., Marozzi V., Presta A., Sterlini B., Contini P., Amore M., Fornaro P., Martino M.
    DOI

    BDNF plasma levels variations in major depressed patients receiving duloxetine

    Neurological Sciences, vol. 36, (no. 5), pp. 729-734